[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100333698":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":19,"responsibleParty":38,"collaborators":40,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"uterine neoplasms",null,"Women with operable and inoperable uterine malignomas (cervical cancer, endometrial cancer, uterine sarcoma)",[13],"Diagnostic Test: uterine neoplasms",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","Analysis of circulating (CTC) and disseminating tumor cells (DTC), determination of Human Papilloma Virus (HPV), Douglas cytology, DNA analysis in blood, proteome analysis, sentinel lymph node detection",[9],[20],{"facility":21,"status":22,"city":23,"state":10,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"University Hospital Tuebingen, Department of Women's Health","RECRUITING","Tübingen","72076","Germany",{"type":27,"coordinates":28},"Point",[29,30],9.05222,48.52266,{"lat":30,"lon":29},[33],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Miriam Linneweh, Dr","CONTACT","+4970712982211","miriam.linneweh@med.uni-tuebingen.de",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[41,43,45],{"name":42,"class":6},"University Hospital Heidelberg",{"name":44,"class":6},"University of Homburg",{"name":46,"class":6},"University Hospital Freiburg","100333698",false,"NCT03624712","Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms","Prospective, Tricentric Open Trial on the Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms","Inclusion Criteria:\n\n* Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)\n* If operable: surgical primary therapy: laparoscopic\u002Frobot-assisted or open radical gyneco-oncological surgery\n* Written consent\n* Willingness and ability to participate in all study-specific procedures\n* Age ≥ 18 years\n\nExclusion Criteria:\n\n* Severe and acute general disease in the last 4 weeks\n* Acute or chronic psychiatric disorders\n* Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)","FEMALE","18 Years",{"count":56,"type":57},580,"ESTIMATED","OBSERVATIONAL","Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm",[61],"Uterine Neoplasms","2025-01-15",{"date":64,"type":65},"2025-01-17","ACTUAL",{"date":67,"type":65},"2012-01",{"date":69,"type":57},"2027-12",{"name":5,"class":6},1]